The Roche Organ Transplantation Research Foundation (ROTRF) has
awarded research grants to five U.S. teams to support work designed
to advance the science of solid organ transplantation.
"The Trustees hope that the funds available through the Foundation
will permit transplantation researchers to develop new technologies
and areas of interest, and will encourage researchers in other
areas to study transplantation problems," said Philip Halloran,
M.D., Professor of Medicine at the University of Alberta and Chairman
of the Foundation's Board of Trustees
The research grants were awarded to teams headed by:
+ Dr. Maria-Luisa Alegre, University of Chicago, Chicago, IL
for research on "The role of costimulatory molecules in cardiac
allograft rejection;"
+ Dr. Michael Autieri, Temple University School of Medicine,
Philadelphia, PA for research on "Characterization of expression
and growth enhancing properties of AIF-1 in VSMC of injured arteries;"
+ Dr. Debra Hullett, University of Wisconsin, Madison, WI for
research on the "Effect of vitamin D on renal allograft function;"
+ Dr. Dianne McKay, Dana Farber Cancer Institute/Harvard Medical
School, Boston, MA for research on "Alterations in IL-2R signaling
induced by anti-IL-2R antibodies;" and-
+ Prof. Simon Robson, Beth Israel Deaconess/Harvard University,
Boston, MA for research on "Disordered thromboregulation in xenotransplantation."